Redirecting to https://apnews.com/press-release/pr-newswire/d3-bio-presents-first-line-data-for-elisrasib-d3s-001-at-asco-2026-next-generation-kras-g12c-inhibitor-shows-landmark-efficacy-in-untreated-nsclc-0aaa291d69a45170e972414ef4b44cdb